Clinical Study Results
The table below shows how many participants had adverse reactions during the study.
Adverse reactions during the study
AZD8871 Placebo Anoro Ellipta
(out of 70 (out of 68 (out of 69
participants) participants participants)
How many participants had adverse
7.1% (5) 2.9% (2) 10.1% (7)
reactions during the study?
How many participants had serious
0.0% (0) 0.0% (0) 0.0% (0)
adverse reactions during the study?
How many participants stopped
0.0% (0) 0.0% (0) 0.0% (0)
treatment due to adverse reactions?
What adverse reactions did the participants have?
The most common adverse reaction during the study was headache.
The tables below show the adverse reactions that happened during the study.
Adverse reactions during the study
AZD8871 Placebo Anoro Ellipta
(out of 70 (out of 68 (out of 69
participants) participants participants)
Headache 4.3% (3) 2.9% (2) 8.7% (6)
Cough 1.4% (1) 0.0% (0) 0.0% (0)
Irregular heart beat 1.4% (1) 0.0% (0) 0.0% (0)
Seasonal allergy 1.4% (1) 0.0% (0) 0.0% (0)
Diarrhea 0.0% (0) 0.0% (0) 1.4% (1)
How has this study helped patients and researchers?
This study helped researchers learn more about AZD8871 to help people who have COPD.
Researchers look at the results of many studies to decide which treatments work best and are
safest. This summary shows only the main results from this one study. Other studies may provide
new information or different results.
Further clinical studies with AZD8871 are planned.
7